Objective
Enteral nutrition (EN) has been implicated as a risk factor for ventilator-associated pneumonia (VAP). We explored the incidence of VAP and its association with clinical and nutrition-related therapies in mechanically ventilated children.
Design
Prospective, multicenter, cohort study.
Setting
59 Pediatric intensive Care Units in 15 countries.
Patients
Children < 18 years of age, mechanically ventilated >48 hours.
Interventions
None. Multivariable logistic regression to determine factors associated with VAP.
Measurements and Major Results
Data are presented as median (IQR) or counts (%). We enrolled 1245 subjects (45% female, 42% surgical), age 20 (4, 84) months and duration of mechanical ventilation 7 days (3, 13). Culture-positive VAP was diagnosed in 80 (6.4%) patients; duration of mechanical ventilation for this subgroup was 17 days (8, 39). Enteral nutrition was delivered in 985 (79%) patients, initiated within 48 hours in 592 (60%) patients, and via post-pyloric route in 354 (36%) patients. Acid-suppressive agents were used in 763 (61%) patients. The duration of EN (p = 0.21), route (gastric vs. postpyloric) of delivery (p = 0.94), severity of illness (p = 0.17), and diagnostic category on admission (p = 0.31) were not associated with VAP. After adjusting for EN days, illness severity, and site; VAP was significantly associated with mechanical ventilation >10 days (OR 3.7, 95% CI: 2.2-6.5, p < 0.001), PICU length of stay >10 days (OR 1.8, 95% CI: 1.1-3.1, p = 0.029), and use of acid-suppressive medication (OR 2.0, 95% CI: 1.2-3.6, p = 0.011).
Conclusions
VAP was diagnosed in 6.5% of mechanically ventilated children in a heterogeneous multicenter cohort. We did not find a link between enteral nutrition duration or route of delivery and VAP. In addition to duration of mechanical ventilation and length of PICU stay; the use of acid-suppressive therapy independently increased the likelihood of developing VAP in this population. This association must be further explored in clinical trials.